GLP1R and type 2 diabetes mellitus: The time to reach maximum plasma concentration (Tmax) is 30 min for dorzagliatin-modulated GLP-1 secretion, which was similar in T2D subjects compared to NGT subjects [23, 24], suggesting that dorzagliatin acts on intestinal L cells and improves GLP-1 secretion in T2D patients.